|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Apr―25 |
SARS-CoV-2 tropism to intestinal but not gastric epithelial cells is defined by limited ACE2 expression |
Mindaugas Paužuolis, Diana Fatykhova, Boris Zühlke, Torsten Schwecke, Mastura Neyazi, Pilar Samperio-Ventayol, et al. (+7) Carmen Aguilar, Nicolas Schlegel, Simon Dökel, Markus Ralser, Andreas Hocke, Christine Krempl, Sina Bartfeld |
2 |
[GO] |
2024―Mar―28 |
Micro-patterned culture of iPSC-derived alveolar and airway cells distinguishes SARS-CoV-2 variants |
Atsushi Masui, Rina Hashimoto, Yasufumi Matsumura, Takuya Yamamoto, Miki Nagao, Takeshi Noda, et al. (+2) Kazuo Takayama, Shimpei Gotoh |
3 |
[GO] |
2023―Oct―26 |
Businesses marketing purported stem cell treatments and exosome therapies for COVID-19: An analysis of direct-to-consumer online advertising claims |
Leigh Turner, Juan Ramon Martinez, Shemms Najjar, Thevin Rajapaksha Arachchilage, Jia Chieng Wang |
4 |
[GO] |
2023―Sep―12 |
Genome-wide loss-of-function screen using human pluripotent stem cells to study virus-host interactions for SARS-CoV-2 |
Ariel Pagis, Or Alfi, Shay Kinreich, Atilgan Yilmaz, Marah Hamdan, Aseel Gadban, et al. (+3) Amos Panet, Dana G. Wolf, Nissim Benvenisty |
5 |
[GO] |
2023―Jun―13 |
Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatment |
Rajeev Rudraraju, Matthew J. Gartner, Jessica A. Neil, Elizabeth S. Stout, Joseph Chen, Elise J. Needham, et al. (+22) Michael See, Charley Mackenzie-Kludas, Leo Yi Yang Lee, Mingyang Wang, Hayley Pointer, Kathy Karavendzas, Dad Abu-Bonsrah, Damien Drew, Yu Bo Yang Sun, Jia Ping Tan, Guizhi Sun, Abbas Salavaty, Natalie Charitakis, Hieu T. Nim, Peter D. Currie, Wai-Hong Tham, Enzo Porrello, Jose M. Polo, Sean J. Humphrey, Mirana Ramialison, David A. Elliott, Kanta Subbarao |
6 |
[GO] |
2023―Apr―20 |
Organotypic human lung bud microarrays identify BMP-dependent SARS-CoV-2 infection in lung cells |
E.A. Rosado-Olivieri, B. Razooky, J. Le Pen, R. De Santis, D. Barrows, Z. Sabry, et al. (+6) H.-H. Hoffmann, J. Park, T.S. Carroll, J.T. Poirier, C.M. Rice, A.H. Brivanlou |
7 |
[GO] |
2023―Feb―23 |
SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants |
Lisiena Hysenaj, Samantha Little, Kayla Kulhanek, Melia Magnen, Kriti Bahl, Oghenekevwe M. Gbenedio, et al. (+36) Morgan Prinz, Lauren Rodriguez, Christopher Andersen, Arjun Arkal Rao, Alan Shen, Jean-Christophe Lone, Leonard C. Lupin-Jimenez, Luke R. Bonser, Nina K. Serwas, Eran Mick, Mir M. Khalid, Taha Y. Taha, Renuka Kumar, Jack Z. Li, Vivianne W. Ding, Shotaro Matsumoto, Mazharul Maishan, Bharath Sreekumar, Camille Simoneau, Irina Nazarenko, Michael G. Tomlinson, Khajida Khan, Anne von Gottberg, Alex Sigal, Mark R. Looney, Gabriela K. Fragiadakis, David M. Jablons, Charles R. Langelier, Michael Matthay, Matthew Krummel, David J. Erle, Alexis J. Combes, Anita Sil, Melanie Ott, Johannes R. Kratz, Jeroen P. Roose |
8 |
[GO] |
2022―Jun―23 |
Conjunctival epithelial cells resist productive SARS-CoV-2 infection |
Robert M. Jackson, Catherine F. Hatton, Jarmila Stremenova Spegarova, Maria Georgiou, Joseph Collin, Emily Stephenson, et al. (+19) Bernard Verdon, Iram J. Haq, Rafiqul Hussain, Jonathan M. Coxhead, Hardeep-Singh Mudhar, Bart Wagner, Megan Hasoon, Tracey Davey, Paul Rooney, C.M. Anjam Khan, Chris Ward, Malcolm Brodlie, Muzlifah Haniffa, Sophie Hambleton, Lyle Armstrong, Francisco Figueiredo, Rachel Queen, Christopher J.A. Duncan, Majlinda Lako |
9 |
[GO] |
2022―May―10 |
SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe |
George D. Vavougios, Sotirios G. Zarogiannis, Georgios Hadjigeorgiou, Karen A. Krogfelt, Konstantinos I. Gourgoulianis |
10 |
[GO] |
2022―May―10 |
Response to: SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe |
Susanne Krasemann, Markus Glatzel, Ole Pless |
11 |
[GO] |
2022―Apr―21 |
The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research |
Lars Muhl, Liqun He, Ying Sun, Maarja Andaloussi Mäe, Riikka Pietilä, Jianping Liu, et al. (+22) Guillem Genové, Lei Zhang, Yuan Xie, Stefanos Leptidis, Giuseppe Mocci, Simon Stritt, Ahmed Osman, Andrey Anisimov, Karthik Amudhala Hemanthakumar, Markus Räsänen, Emil M. Hansson, Johan Björkegren, Michael Vanlandewijck, Klas Blomgren, Taija Mäkinen, Xiao-Rong Peng, Yizhou Hu, Patrik Ernfors, Thomas D. Arnold, Kari Alitalo, Urban Lendahl, Christer Betsholtz |
12 |
[GO] |
2022―Mar―25 |
SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids |
Yotam Menuchin-Lasowski, André Schreiber, Aarón Lecanda, Angeles Mecate-Zambrano, Linda Brunotte, Olympia E. Psathaki, et al. (+3) Stephan Ludwig, Thomas Rauen, Hans R. Schöler |
13 |
[GO] |
2022―Mar―25 |
Is hypoimmunogenic stem cell therapy safe in times of pandemics? |
Friederike Matheus, Tal Raveh, Anthony E. Oro, Marius Wernig, Micha Drukker |
14 |
[GO] |
2022―Feb―17 |
A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4 |
Zhangjing Ma, Xisheng Li, Rebecca L.Y. Fan, Kevin Y. Yang, Calvin S.H. Ng, Rainbow W.H. Lau, et al. (+11) Randolph H.L. Wong, Kevin K. Ng, Chi Chiu Wang, Peng Ye, Zelong Fu, Alex W.H. Chin, M.Y. Alison Lai, Yu Huang, Xiao Yu Tian, Leo L.M. Poon, Kathy O. Lui |
15 |
[GO] |
2022―Feb―17 |
Genome-wide analyses reveal the detrimental impacts of SARS-CoV-2 viral gene Orf9c on human pluripotent stem cell-derived cardiomyocytes |
Juli Liu, Yucheng Zhang, Lei Han, Shuai Guo, Shiyong Wu, Emma Helen Doud, et al. (+5) Cheng Wang, Hanying Chen, Michael Rubart-von der Lohe, Jun Wan, Lei Yang |
16 |
[GO] |
2022―Jan―20 |
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2 |
Susanne Krasemann, Undine Haferkamp, Susanne Pfefferle, Marcel S. Woo, Fabian Heinrich, Michaela Schweizer, et al. (+35) Antje Appelt-Menzel, Alevtina Cubukova, Janica Barenberg, Jennifer Leu, Kristin Hartmann, Edda Thies, Jessica Lisa Littau, Diego Sepulveda-Falla, Liang Zhang, Kathy Ton, Yan Liang, Jakob Matschke, Franz Ricklefs, Thomas Sauvigny, Jan Sperhake, Antonia Fitzek, Anna Gerhartl, Andreas Brachner, Nina Geiger, Eva-Maria König, Jochen Bodem, Sören Franzenburg, Andre Franke, Stefan Moese, Franz-Josef Müller, Gerd Geisslinger, Carsten Claussen, Aimo Kannt, Andrea Zaliani, Philip Gribbon, Benjamin Ondruschka, Winfried Neuhaus, Manuel A. Friese, Markus Glatzel, Ole Pless |
17 |
[GO] |
2021―Oct―16 |
Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic |
Leigh Turner, Megan Munsie, Aaron D. Levine, Laertis Ikonomou |
18 |
[GO] |
2021―Oct―13 |
Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2 |
Liuliu Yang, Benjamin E. Nilsson-Payant, Yuling Han, Fabrice Jaffré, Jiajun Zhu, Pengfei Wang, et al. (+20) Tuo Zhang, David Redmond, Sean Houghton, Rasmus Møller, Daisy Hoagland, Lucia Carrau, Shu Horiuchi, Marisa Goff, Jean K. Lim, Yaron Bram, Chanel Richardson, Vasuretha Chandar, Alain Borczuk, Yaoxing Huang, Jenny Xiang, David D. Ho, Robert E. Schwartz, Benjamin R. tenOever, Todd Evans, Shuibing Chen |
19 |
[GO] |
2021―Sep―01 |
Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells |
Jessika Iwanski, Sobhi G. Kazmouz, Shuaizhi Li, Ben Stansfield, Tori T. Salem, Samantha Perez-Miller, et al. (+10) Toshinobu Kazui, Lipsa Jena, Jennifer L. Uhrlaub, Scott Lick, Janko Nikolich-Žugich, John P. Konhilas, Carol C. Gregorio, May Khanna, Samuel K. Campos, Jared M. Churko |
20 |
[GO] |
2021―Jul―20 |
Cardiomyocytes Recruit Monocytes upon SARS-CoV-2 Infection by Secreting CCL2 |
Liuliu Yang, Benjamin E. Nilsson-Payant, Yuling Han, Fabrice Jaffré, Jiajun Zhu, Pengfei Wang, et al. (+18) Tuo Zhang, David Redmond, Sean Houghton, Rasmus Møller, Lucia Carrau, Shu Horiuchi, Marisa Goff, Jean K. Lim, Yaron Bram, Chanel Richardson, Vasuretha Chandar, Yaoxing Huang, Jenny Xiang, David D. Ho, Robert E. Schwartz, Benjamin R. tenOever, Todd Evans, Shuibing Chen |
21 |
[GO] |
2021―May―11 |
Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2 |
Shima Shahbaz, Lai Xu, Mohammed Osman, Wendy Sligl, Justin Shields, Michael Joyce, et al. (+3) D. Lorne Tyrrell, Olaide Oyegbami, Shokrollah Elahi |
22 |
[GO] |
2021―May―11 |
SARS-CoV-2 targets glial cells in human cortical organoids |
Courtney L. McMahon, Hilary Staples, Michal Gazi, Ricardo Carrion, Jenny Hsieh |
23 |
[GO] |
2021―Apr―15 |
Human Pluripotent Stem Cell-Derived Intestinal Organoids Model SARS-CoV-2 Infection Revealing a Common Epithelial Inflammatory Response |
Aditya Mithal, Adam J. Hume, Jonathan Lindstrom-Vautrin, Carlos Villacorta-Martin, Judith Olejnik, Esther Bullitt, et al. (+3) Anne Hinds, Elke Mühlberger, Gustavo Mostoslavsky |
24 |
[GO] |
2021―Mar―10 |
The Organoid Platform: Promises and Challenges as Tools in the Fight against COVID-19 |
Maarten H. Geurts, Jelte van der Vaart, Joep Beumer, Hans Clevers |
25 |
[GO] |
2021―Mar―10 |
Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks |
Miao Cao, Xiaojie Su, Shibo Jiang |
26 |
[GO] |
2021―Feb―15 |
Human intestinal organoids recapitulate enteric infections of enterovirus and coronavirus |
Xiaoyu Zhao, Cun Li, Xiaojuan Liu, Man Chun Chiu, Dong Wang, Yuxuan Wei, et al. (+8) Hin Chu, Jian-Piao Cai, Ivy Hau-Yee Chan, Kenneth Kak-Yuen Wong, Jasper Fuk-Woo Chan, Kelvin Kai-Wang To, Kwok Yung Yuen, Jie Zhou |
27 |
[GO] |
2021―Feb―15 |
Common genetic variation in humans impacts in vitro susceptibility to SARS-CoV-2 infection |
Kristina Dobrindt, Daisy A. Hoagland, Carina Seah, Bibi Kassim, Callan P. O’Shea, Aleta Murphy, et al. (+18) Marina Iskhakova, Michael B. Fernando, Samuel K. Powell, P.J. Michael Deans, Ben Javidfar, Cyril Peter, Rasmus Møller, Skyler A. Uhl, Meilin Fernandez Garcia, Masaki Kimura, Kentaro Iwasawa, John F. Crary, Darrell N. Kotton, Takanori Takebe, Laura M. Huckins, Benjamin R. tenOever, Schahram Akbarian, Kristen J. Brennand |
28 |
[GO] |
2021―Feb―15 |
Revealing tissue-specific SARS-CoV-2 infection and host responses using human stem cell derived lung and cerebral organoids |
Shashi Kant Tiwari, Shaobo Wang, Davey Smith, Aaron Carlin, Tariq M. Rana |
29 |
[GO] |
2021―Feb―15 |
SARS-CoV-2 infects human pluripotent stem cell-derived cardiomyocytes, impairing electrical and mechanical function |
Silvia Marchiano, Tien-Ying Hsiang, Akshita Khanna, Ty Higashi, Leanne S. Whitmore, Johannes Bargehr, et al. (+14) Hongorzul Davaapil, Jean Chang, Elise Smith, Lay Ping Ong, Maria Colzani, Hans Reinecke, Xiulan Yang, Lil Pabon, Sanjay Sinha, Behzad Najafian, Nathan J. Sniadecki, Alessandro Bertero, Michael Gale, Charles E. Murry |
30 |
[GO] |
2021―Feb―15 |
Neurotropic effects of SARS-CoV-2 modeled by the human brain organoids |
Anand Ramani, Pranty Abida Islam, Jay Gopalakrishnan |
31 |
[GO] |
2021―Feb―06 |
Human erythroid progenitors are directly infected by SARS-CoV-2: implications for emerging erythropoiesis in severe COVID19 patients. |
Hector Huerga Encabo, William Grey, Manuel Garcia-Albornoz, Henry Wood, Rachel Ulferts, Iker Valle Aramburu, et al. (+5) Austin G. Kulasekararaj, Ghulam Mufti, Venizelos Papayannopoulos, Rupert Beale, Dominique Bonnet |
32 |
[GO] |
2020―Dec―11 |
Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails |
Loukia Yiangou, Richard P. Davis, Christine L. Mummery |
33 |
[GO] |
2020―Sep―11 |
Human Mesenchymal Stromal Cells are resistant to SARS-CoV-2 Infection under Steady State, Inflammatory Conditions and in the Presence of SARS-CoV-2 infected Cells |
Richard Schäfer, Gabriele Spohn, Marco Bechtel, Denisa Bojkova, Patrick C. Baer, Selim Kuçi, et al. (+3) Erhard Seifried, Sandra Ciesek, Jindrich Cinatl |
34 |
[GO] |
2020―Apr―02 |
Message from the Editor: Stem Cell Science in the Time of COVID-19 |
Martin Pera |
|